Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3676911010 | Atovaquone 250 mg and proguanil 100 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3676913013 | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
46701201000001115 | Atovaquone 250mg / Proguanil 100mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
59645001000001114 | Proguanil 100mg / Atovaquone 250mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Atovaquone+proguanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Biguanide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product containing precisely proguanil hydrochloride 100 milligram/1 each conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product containing atovaquone and proguanil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product containing proguanil in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Proguanil | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has basis of strength substance | Atovaquone | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product containing atovaquone and proguanil in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has precise active ingredient | Proguanil | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Product containing only atovaquone and proguanil in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has active ingredient | Proguanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has specific active ingredient | Atovaquone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has specific active ingredient | Proguanil hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atovaquone+proguanil hydrochloride 250mg/100mg tablet - product | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone 250mg/100mg tablets (Pilsco Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone tablets (GlaxoSmithKline) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone 250mg/100mg tablets (CST Pharma Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Atovaquone 250mg / Proguanil 100mg tablets 12 tablet | Is pack of | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone 250mg/100mg tablets (DE Pharmaceuticals) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone tablets (Waymade Healthcare Plc) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Atovaquone 250mg / Proguanil 100mg tablets 12 tablet | Has VMP | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Malarone tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (A A H Pharmaceuticals Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Glenmark Generics (Europe) Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Alliance Healthcare (Distribution) Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Reprapog 250mg/100mg tablets (Sandoz Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Mafamoz 250mg/100mg tablets (Teva UK Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets (Viatris UK Healthcare Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd) | Is a | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets 36 tablet | Has VMP | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Proguanil 100mg / Atovaquone 250mg tablets 24 tablet | Has VMP | False | Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets